Label Changes for:
Elestrin (estradiol gel)
Changes have been made to the CONTRAINDICATIONS, WARNINGS and PRECAUTIONS sections of the safety label.
Elestrin should not be used in women with any of the following conditions:
- Known anaphylactic reaction or angioedema to Elestrin
- Known protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders
WARNINGS AND PRECAUTIONS
- Exogenous estrogens may exacerbate symptoms of angioedema in women with hereditary angioedema